2014
DOI: 10.1177/1533317514524813
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Tolerability of Benzodiazepines for the Treatment of Behavioral and Psychological Symptoms of Dementia

Abstract: The objective of this review is to summarize the available data on the use of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia (BPSD) from randomized controlled trials (RCTs). A systematic search of 5 major databases, PubMed, MEDLINE, PsychINFO, EMBASE, and Cochrane Collaboration, yielded a total of 5 RCTs. One study compared diazepam to thioridazine, 1 trial compared oxazepam to haloperidol and diphenhydramine, 1 trial compared alprazolam to lorazepam, 1 trial compared lo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(36 citation statements)
references
References 55 publications
0
34
0
2
Order By: Relevance
“…Benzodiazepines (in our sample: diazepam, medazepam, clobazam, chlordiazepoxide, nitrazepam) and benzodiazepine-related drugs (in our sample: zolpidem, zopiclone) are often used in older adults for the treatment of insomnia, depression, or anxiety. In addition, they are used often to treat behavioral symptoms of dementia, despite the lack of evidence for their effectiveness [48]. …”
Section: Discussionmentioning
confidence: 99%
“…Benzodiazepines (in our sample: diazepam, medazepam, clobazam, chlordiazepoxide, nitrazepam) and benzodiazepine-related drugs (in our sample: zolpidem, zopiclone) are often used in older adults for the treatment of insomnia, depression, or anxiety. In addition, they are used often to treat behavioral symptoms of dementia, despite the lack of evidence for their effectiveness [48]. …”
Section: Discussionmentioning
confidence: 99%
“…Midazolam was commonly used, which is of concern given the lack of evidence for benzodiazepines in managing acute agitation in the elderly, their potential to worsen delirium,10 and the limited circumstances in which they are appropriate in the management of BPSD 30. Doses of haloperidol up to maximum 5 mg are of significant concern given its propensity for extrapyramidal side effects, dose-related mortality, and significant risk in dementia with Lewy bodies.…”
Section: Discussionmentioning
confidence: 99%
“…Older people have increased sensitivity to adverse events, despite growing tolerance to the sedative effects [12]. Adverse events include daytime drowsiness, lethargy, fatigue, agitation, memory loss, impaired coordination and falls [14]. Benzodiazepines may also contribute to cognitive decline in people with dementia [15].…”
Section: Introductionmentioning
confidence: 99%